American Oriental Bioengineering Inc
American Oriental Bioengineering, Inc. engages in the development, manufacture, and commercialization of various pharmaceutical and healthcare products. The company primarily provides prescription pharmaceutical products, including Shuanghuanglian Lyophilized Injection Powder under the SHL brand for the treatment of flu symptoms, such as high fever, cough, and sore throat, as well as upper respiratory infections, mild pneumonia, bronchitis, and tonsillitis; and Cease Enuresis Soft Gel under the CE Gel brand to alleviate bedwetting. It also offers over-the-counter pharmaceutical products comprising Cease Enuresis Patch for the treatment of bedwetting and incontinence; Jinji Capsule for the treatment of endometritis, annexitis, and pelvic inflammations; Jinji Yimucao for the treatment of premenstrual syndrome (PMS) and other PMS and menopause-related symptoms; and Boke Nasal Spray for the treatment of sinus congestion from common cold, stuffy nose, chronic rhinitis, allergic rhinitis, and nasosinusitis. In addition, the company provides various nutraceutical products, such as soybean peptide based drinks, tablets, powder, and instant coffee. Further, it is involved in the wholesale and retail of pharmaceutical and nutraceutical products. The company sells its products directly and through distributors to hospitals, clinics, pharmacies, supermarkets, fitness centers, specialty nutraceutical stores, and other retail outlets in the People's Republic of China. American Oriental Bioengineering, Inc. is headquartered in Beijing, China. Show More...
-
Website -
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 0.00 USD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2003-12 2004-12 2005-12 2006-12 2007-12 2008-12 2009-12 2010-12 2011-12 2012-12 TTM Earnings Per Share USD 150.3 230.46 310.62 460.92 611.22 611.22 1062.12 185.37 -901.8 -781.56 -1227.45 Dividends USD Payout Ratio % * Shares Mil Book Value Per Share * USD 1035.07 2215.74 4184.08 4364.74 5047.36 5486.86 5837.44 Free Cash Flow Per Share * USD 147.39 240.49 577.27 -1156.35 227.92 25.82 150.3 Return on Assets % 28.3 24.09 18.88 20.51 16.06 10.89 7.53 2.75 -11.47 -11.81 -19.6 Financial Leverage (Average) 1.17 1.29 1.1 1.19 1.13 1.52 1.46 1.42 1.48 1.36 1.51 Return on Equity % 34.16 30.09 21.7 23.67 18.45 14.52 11.2 3.96 -16.61 -16.84 -28.19 Return on Invested Capital % 30.79 26.69 20.26 22.23 17.65 12.03 9.19 3.76 -12.01 -12.52 -22.59 Interest Coverage 10.49 5.18 -9.27 -8.86 Current Ratio 4.39 2.55 8.8 4.95 7.82 2.88 3.79 4.68 1.23 0.9 0.51 Quick Ratio 2.75 1.71 7.69 4.38 7.0 2.35 3.16 3.97 0.95 0.54 0.24 Debt/Equity 0.010 0.010 0.34 0.29 0.27 0.02